Arnar Masson, born in 1971, is an independent advisor and board member. Masson is currently on the Board of Directors of Siminn, the largest telecom company in Iceland, listed on Nasdaq Iceland, where he also serves on the Renumeration Committee. He also serves on the Board of Directors of Íslandshótel, Iceland’s largest hotel chain. Arnar is a member of the University Council of the University of Iceland and is a board member of Festa – Center for Sustainability in Iceland.

Masson was Chief Human Resources and Strategy Officer at Isavia, a company that handles the operations and development of all airports in Iceland. Prior to that, he was an alternate director at the European Bank for Reconstruction and Development (EBRD) in London, an investment and development bank that works primarily with private sector clients in developing economies.

Before joining EBRD, Masson worked in the Government Offices in Iceland, first in the Ministry of Finance and later as Director General in the Prime Minister’s Office. From 2000 to 2008, Masson held an adjunct lecturer position at the Department of Political Science at the University of Iceland. Masson has experience in strategy development and implementation, human resources, Environmental, Social and Governance (ESG), mergers and acquisitions (M&A), political affairs and has worked in emerging markets. He has completed executive courses for board directors both at Harvard Business School and IMD.

Masson has no interest links with the company’s main customers, competitors or major shareholders.

EDUCATION MSc, Comparative Politics, London School of Economics and Political Science BA, Political Science, University of Iceland

ELECTED 2021 Chairman of the Board 2013 Vice-Chairman  2001 Board Director 

SUB-COMMITTEES Remuneration Committee (Chair) Nomination Committee

Olafur Gudmundsson, born in 1969, is currently the Head of Discovery Pharmaceutics and Analytical Sciences at Bristol- Myers Squibb (BMS), a global biopharmaceutical company.

For more than two decades, Gudmundsson has held roles of increasing responsibility within research and development, covering multiple therapeutic areas and stages of drug discovery, both for Bristol-Myers Squibb and Genentech. At BMS, Gudmundsson has helped bring multiple drug candidates to clinical trials, several of which have become marketed products.

In his time within the pharmaceutical industry, Gudmundsson’s responsibilities have included involvement with global portfolio strategy, evaluation of external acquisitions, strategic innovations, and integration of merged companies. He has participated in governance teams providing input on global portfolio optimization and prioritization, led process optimization teams and chaired integration teams.

Gudmundsson is also associated with the graduate program of the Pharmaceutical Chemistry department at Purdue University. Currently, Gudmundsson is a Board member of Eyrir Invest and Noruz.

Gudmundsson has no interest links with the Company’s main customers. He is a member of the Board of Directors of Eyrir Invest, Marel’s largest shareholder.

EDUCATION PhD, Pharmaceutical Chemistry, University of Kansas Cand. pharm., Pharmacy, University of Iceland

ELECTED 2021 Vice-Chairman 2014 Board Director

SUB-COMMITTEES Remuneration Committee Nomination Committee

Ann Elizabeth Savage, born in 1957, most recently worked for Gousto, a UK meal kit manufacturer and –retailer. She worked for Gousto from 2018 to 2022 in an advisory role and headed the Food Technical function.

Savage previously served as Group Technical Director of Bakkavor. Her primary responsibilities have included food safety, health and safety management, manufacturing excellence and corporate social responsibility management in the UK, US and Asia. She has held a variety of roles in technical and research and development departments within the retail and food industry over her 40-year career. She worked for the Cooperative Wholesale Society (CWS), Northern Foods from 1990 until 1999 and at Geest/Bakkavor for over 19 years.

Savage’s responsibilities have included representing businesses with UK regulators such as Food Standards Agency, Department for Environment Food and Rural Affairs and Health Protection England. She has chaired the Food Network for Ethical Trade, the IGD Technical Leadership Forum and has been a member of the advisory group for the Better Regulation Task Force and the British Retail Consortium Advisory Board. Savage has worked closely with UK retailers to deliver on their corporate social responsibility commitments and to develop reporting procedures. She has experience in operational management, product development and incident management. She has worked with Farm Africa in Tanzania and Kenya to support African endeavors in tilapia fish farming and beekeeping. She is a member of her parish council and previously served as a Governor of Boston College, a college of further education in the UK.

Savage has no interest links with the company’s main customers, competitors, or major shareholders.

EDUCATION Post Graduate Diploma in Management Studies, Nottingham University Mathematics, Technology and Systems Management, Open University

ELECTED 2013 Board Director

SUB-COMMITTEES Audit Committee

Astvaldur Johannsson, born in 1961, is Business Development Director at Controlant, a global real-time monitoring software solution (IoT) provider focusing on the pharmaceutical industry. Previously, Johannsson was a Board member of Festi, a holding company that focuses on investments and support services for its five operating companies: Bakkinn voruhotel, ELKO, Festi Fasteignir, Kronan and N1. Shares in Festi are listed on the Nasdaq Iceland Stock Exchange.

His previous international business experience includes senior management positions at Össur, a global medical devices manufacturer and as an Executive Director leading the international division of Valitor, an e-commerce payment solutions and services provider. Johannsson also served as a member of the Executive Team of the IT company Nýherji, as Sales and Marketing Director at Penninn, and as a system analyst expert in the IT sector focusing on process design and development.

Johannsson has extensive international leadership experience in different markets across the EU, US and Asia, and in cross-functional environments, both at the executive and board level. He has comprehensive experience in formulating and implementing policy and strategy, and in leading and integrating new businesses and initiatives to improve business performance. Johannsson has a solid background in managing business-to-business and business-to-consumer sales and marketing, business development, supply chain, outsourcing, negotiating, contracts and product management along with operations knowledge and experience in varying industries with progressive and successful organizations.

Johannsson has no interest links with the company’s main customers, competitors, or major shareholders.

EDUCATION MBA, University of Iceland BSc, Management Information Systems, Heriot-Watt University

ELECTED 2014 Board Director

SUB-COMMITTEES Audit Committee

Lillie Li Valeur, born in 1970, is a Chinese born Danish citizen residing in Germany. Valeur is currently the CEO of Arla Foods in Germany, she also serves as a member of the Board of Directors of Plus Pack, a multinational Denmark-based packaging company.

Valeur has extensive international experience in the food, ingredients, and pharmaceutical industries, with special focus on EMEA, Asia, emerging markets, commercial leadership, innovation, M&A and strategic partnerships. Valeur has served as CEO for Good Food Group and COCIO in Denmark.

Over 19 years with Arla Foods, a leading global dairy company, Valeur held several senior management roles, both in Asia and globally, including VP Greater China, VP South-East Asia and VP Global Milk Based Beverages. Prior to that, she held various international business management positions at Lundbeck in Denmark, Novartis Consumer Health in Shanghai, as well as a management consulting position at Bain & Company in Beijing.

Valeur was a member of Board of Directors, Remuneration Committee and Science & Innovation Committee of Chr. Hansen, a global Denmark-based bioscience company, listed on Nasdaq Copenhagen from 2020 to 2022; a member of the Board of Directors and Audit Committee of AAK, a global Sweden-based plant-based oils and fats company, listed on Nasdaq Stockholm, from 2013 to 2020 and a member of the Board of Directors of Meda, a European Swedish-based specialty pharmaceutical company, from 2015 to 2016.

Valeur has no interest links with the company’s main customers, competitors, or major shareholders.

EDUCATION MBA, China European International Business School Shanghai, China Degree in Medicine, Shanghai Medical University, China

ELECTED 2020 Board Director

SUB-COMMITTEES Nomination Committee (Chair) Remuneration Committee 

Svafa Grönfeldt, born in 1965, is a Professor of Practice at the Massachusetts Institute of Technology (MIT). She is a founding member of MIT’s newest innovation accelerator DesignX, focused on the design and development of technology- and service-based ventures created at MIT.

Grönfeldt is the co-founder of The MET fund, a Cambridge-based seed investment fund. She is the Vice-Chairman of the Board of Directors of Össur, a global leader in orthopedic solutions since 2008, and member of the Board of Directors of Icelandair since 2019, where she is also a member of the Audit Committee and the Strategy Committee.

Within the global life science field, she served as the Chief Organizational and Development Officer of Alvogen and Deputy to the CEO of Actavis Group. For more than twenty years, her executive career has been focused on organizational design for high growth companies, strategy implementation, service process design and performance tracking, as well as the integration of acquired companies and new business units. She is a former President of Reykjavik University.

Grönfeldt has no interest links with Marel’s main customers, competitors, or major shareholders.

EDUCATION Ph.D. from the London School of Economics MSc, Technical and Professional Communication from Florida Institute of Technology 

ELECTED 2021 Board Director

SUB-COMMITTEES Audit Committee (Chair)

Ton van der Laan, born in 1953, is a Dutch national residing in the Netherlands. He currently serves as Chairman of the Supervisory Board of Royal de Heus, a global feed company and as Vice-Chairman of the Board of Directors of Rainforest Alliance in New York. He is a non-executive board member of Dummen Orange.

Van der Laan has extensive experience from several executive roles in the food, feed and commodity industries. He is the former CEO of Nidera, a company globally active in financing and distribution of grains and oilseeds. He also served as Executive Vice President for Cargill Animal Proteins and Animal Nutrition globally and as CEO of Provimi in the Netherlands, one of the global leaders in animal nutrition.

For over 22 years, Van der Laan held several executive roles at Unilever, the Anglo-Dutch consumer food company, where he was located in the Netherlands, UK, Czech Republic and Slovakia. He has also served as the Managing Director of Philips Domestic Appliances and Personal Care. Van der Laan possesses extensive experience in multi-national businesses, strategic planning, portfolio management, acquisitions and company restructuring, large- and small-scale integrations and top team development.

Van der Laan has no interest links with the company’s main customers, competitors, or major shareholders.

EDUCATION New Board Program, Nyenrode Business University MS, Mechanical Engineering, Twente University

ELECTED 2019 Board Director

SUB-COMMITTEES Audit Committee